Stay updated on Gene Therapy XLRP RPGR: Clinical Trial
Sign up to get notified when there's something new on the Gene Therapy XLRP RPGR: Clinical Trial page.

Latest updates to the Gene Therapy XLRP RPGR: Clinical Trial page
- Check6 days agoChange DetectedThe record displays detailed information about the Phase 1/2 gene-therapy study for X-linked retinitis pigmentosa, including its design, participant criteria, locations, and measured outcomes. It also provides study history, a related publication, and protocol and analysis-plan documents.SummaryDifference47%

- Check13 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA general NIH notice about website updates and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unavailable study record.SummaryDifference1%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now shows a 403 Forbidden error page, replacing the study details with an access-denied screen.SummaryDifference18%

Stay in the know with updates to Gene Therapy XLRP RPGR: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gene Therapy XLRP RPGR: Clinical Trial page.